Grinta, a leading healthcare and pharmaceutical solutions company, has announced its acquisition of Citi Clinic, one of Egypt’s most successful primary healthcare service chains. Alongside this milestone, Grinta has secured an undisclosed amount of strategic investment in a funding round led by Beltone Venture Capital and Raed Ventures.
The acquisition grants Grinta access to over 150,000 patients, marking its entry into the care sector and reinforcing its commitment to integrating both online and offline healthcare solutions.
Mohamed Azab, Co-founder and CEO of Grinta, stated: “The acquisition of Citi Clinic is a pivotal moment for Grinta. It not only enables us to enter the care market but also allows us to integrate offline and online services to transform the way healthcare is accessed and delivered. We are excited about what lies ahead as we expand our reach and impact.”
This move aligns with a global trend of B2B pharmaceutical distributors expanding into direct-to-consumer (B2C) healthcare, following the successful models of companies like McKesson and Walgreens. Grinta aims to replicate this strategy by broadening its healthcare services across Egypt and East Africa.
As part of its transformation, Grinta has exited its B2B retail pharmaceutical distribution business in Egypt to fully focus on patient care. The company is also expanding its presence in East Africa by partnering with Egyptian pharmaceutical manufacturers and launching a pharmacy chain in Tanzania through a buy-and-build strategy.
